ロード中...
Anti‐IL5 therapies for asthma
BACKGROUND: This review is the first update of a previously published review in The Cochrane Library (Issue 7, 2015). Interleukin‐5 (IL‐5) is the main cytokine involved in the activation of eosinophils, which cause airway inflammation and are a classic feature of asthma. Monoclonal antibodies target...
保存先:
| 出版年: | Cochrane Database Syst Rev |
|---|---|
| 主要な著者: | , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
John Wiley & Sons, Ltd
2017
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6483800/ https://ncbi.nlm.nih.gov/pubmed/28933516 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/14651858.CD010834.pub3 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|